Live feed07:05:00·28dPRReleasevia QuantisnowZenas BioPharma Announces Submission of Biologics License Application (BLA) to U.S. FDA for Obexelimab in IgG4-RDByQuantisnow·Wall Street's wire, on your screen.ZBIO· Zenas BioPharma Inc.Health Care
